Manufacturers Life Insurance Company, The Savara Inc Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Savara Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 44,956 shares of SVRA stock, worth $140,712. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,956
Previous 41,250
8.98%
Holding current value
$140,712
Previous $166,000
14.46%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SVRA
# of Institutions
129Shares Held
158MCall Options Held
67.6KPut Options Held
29.4K-
Nea Management Company, LLC Timonium, MD24.5MShares$76.6 Million7.93% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$45.6 Million11.08% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$38.7 Million6.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.62MShares$27 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$25.5 Million1.86% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $357M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.